24 HR metronidazole 750 MG Extended Release Oral Tablet — RxCUI 636559
RxNorm drug concept · Semantic clinical drug
RxCUI 636559
Semantic clinical drug · SCD
● Current RxNorm concept 1 FDA product
4 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI636559
Official name24 HR metronidazole 750 MG Extended Release Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asmetroNIDAZOLE 750 MG 24HR Extended Release Oral Tablet
FDA products mapped1
Package NDCs mapped4
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Metronidazole Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Metronidazole Injection is an IV antibiotic for serious infections caused by anaerobic bacteria, such as abdominal, bloodstream, lung, bone, brain or gynecologic infections. It can...
- It's given through a vein as a slow drip, usually by your care team. You'll often get a first larger dose and then repeat doses about every six hours. Your doctor may later switch...
- The more common ones are nausea, vomiting, diarrhea, stomach cramps, a metallic taste and headache. Some people also have irritation at the IV site. Let your nurse know if it bothe...
- Tell your team right away about confusion, dizziness, trouble with balance or speech, seizures, or numbness or tingling in your hands or feet. Also report a severe rash, blistering...
🕸️ Concept Web — How 24 HR metronidazole 750 MG Extended Release Oral... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
24 HR metronidazole 750 MG Extended Release Oral Tablet
RxCUI 636559 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Metronidazole
6922IN
-
Metronidazole
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Metronidazole Extended Release Oral Tablet
372898SCDF -
Metronidazole Oral Product
1164083SCDG -
Metronidazole Pill
1164084SCDG -
Extended Release Oral Tablet
316945DF -
Oral Product
1151131DFG -
Pill
1151133DFG
-
Metronidazole Extended Release Oral Tablet
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Metronidazole 750 MG
330379SCDC
-
Metronidazole 750 MG
Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Metronidazole 750 MG
SCDC · 330379 -
Metronidazole Extended Release Oral Tablet
SCDF · 372898 -
Metronidazole Oral Product
SCDG · 1164083 -
Metronidazole Pill
SCDG · 1164084
📦 FDA Products & Package NDCs
1 product · 4 package NDCs
4 package NDCs map to RxCUI 636559 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 46708-0021-30 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (46708-... | Metronidazole | Alembic Pharmaceuticals Limited | 2010-05-07 |
| 46708-0021-31 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (46708... | Metronidazole | Alembic Pharmaceuticals Limited | 2010-05-07 |
| 46708-0021-50 | 50 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (46708-... | Metronidazole | Alembic Pharmaceuticals Limited | 2010-05-07 |
| 46708-0021-71 | 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (46708... | Metronidazole | Alembic Pharmaceuticals Limited | 2010-05-07 |
Observed labelers:
Alembic Pharmaceuticals Limited (4)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.